| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 13,097 | 0.00 | 51,716 |
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 8.59 | 26,193 | 225.00 k | 26,193 |
| 4 Mar 24 | ADPT Adaptive Biotechnologies | Common Stock | Grant | Acquire A | No | No | 0 | 31,328 | 0.00 | 107,296 |
| 4 Mar 24 | ADPT Adaptive Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 3.99 | 48,044 | 191.70 k | 48,044 |
| 8 Feb 24 | HLVX HilleVax | Common Stock | Grant | Acquire A | No | No | 0 | 174,202 | 0.00 | 1,128,033 |
| 8 Feb 24 | HLVX HilleVax | Common Stock | Sell | Dispose S | No | No | 14.9315 | 11,597 | 173.16 k | 953,831 |
| 8 Feb 24 | HLVX HilleVax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.06 | 226,885 | 3.42 mm | 226,885 |
